Table 1.
Demographic Data | General Cohort (n = 79) | SMO (n = 22) | AKT1 (n = 12) | Others (n = 45) | P |
---|---|---|---|---|---|
Sex | |||||
Male | 17 (21%) | 4 (18%) | 2 (16%) | 11 (25%) | .76 |
Female | 62 (79%) | 18 (82%) | 10 (84%) | 34 (75%) | |
Age, y | |||||
Median | 55 | 55 | 56 | 55 | .94 |
Range | 22–83 | 22–72 | 30–75 | 26–83 | |
Median preoperative KPS | 90 | 90 | 80 | 90 | .95 |
Median FU (mo) | 70 | 83 | 60 | 72 | .18 |
Presenting symptoms | |||||
Headache | 46 (58%) | 12 (54%) | 6 (50%) | 28 (62%) | .68 |
Visual impairment | 33 (41%) | 13 (59%) | 3 (25%) | 17 (38%) | .11 |
Anosmia | 56 (71%) | 20 (91%) | 7 (58%) | 29 (64%) | .04 |
Cognitive impairment | 38 (48%) | 13 (59%) | 5 (42%) | 20 (45%) | .47 |
Seizures | 4 (5%) | 2 (9%) | 1 (8%) | 1 (2%) | .41 |
Imaging data | |||||
Size | |||||
Mean tumor diameter (mm) | 59 | 63 | 54 | 51 | .28 |
Range | 30–90 | 35–80 | 30–90 | 30–70 | |
Hyperostotic bone | 52 (66%) | 17 (77%) | 6 (50%) | 29 (65%) | .26 |